Form 4: Astrana Health Repurchases Shares, Including Restricted Stock

Astrana Health, Inc. repurchased 5,100 shares of its common stock, including restricted stock, on December 10, 2024.

Summary

• Astrana Health, Inc. repurchased a total of 5,100 shares of its common stock on December 10, 2024.
• The repurchase included 3,564 shares of restricted stock.
• These restricted shares will vest on the earlier of August 13, 2025, or the date of the company's 2025 annual meeting of stockholders.
• The shares were repurchased at a price of $43.09 per share, totaling $14,611.

Sentiment

Score: 6

Explanation: The document describes a routine share repurchase, which is generally neutral to slightly positive. The vesting of restricted stock is a standard practice.

Positives

• The share repurchase may indicate management's confidence in the company's value.

Risks

• The vesting of restricted stock could potentially dilute existing shareholders if not managed carefully.

Industry Context

Share repurchases are a common practice for companies to return value to shareholders or to offset dilution from stock-based compensation.

Comparison to Industry Standards

• Share repurchases are a common capital allocation strategy used by companies across various industries.
• The size of this repurchase is relatively small compared to large-cap companies, but it is not unusual for a company of Astrana Health's size.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also engage in share repurchases, but typically on a much larger scale.

Stakeholder Impact

• Shareholders may view the repurchase positively as it can increase earnings per share.
• The vesting of restricted stock could potentially dilute existing shareholders.

Key Dates

Keywords

share repurchase, restricted stock, common stock, vesting, Astrana Health